M&A
Castle Creek Pharmaceutical Holdings Announces Agreement to Acquire Fibrocell
Castle Creek Pharmaceuticals, LLC
PR-M09-19-NI-044Sep 18, 2019
Investment
Castle Creek Pharma Raises Funding to Repurpose Diacerein
Nice Insight
PAO-M10-18-NI-030Oct 29, 2018
Treatment
Castle Creek Pharmaceuticals Receives FDA Fast Track Designation for Diacerein 1% Ointment for Treatment of Epidermolysis Bullosa Simplex
Castle Creek Pharmaceuticals
PR-M08-18-NI-120Aug 31, 2018
Clinical Research
Castle Creek Pharmaceuticals Announces Data Validating First Investigator's Global Assessment Scale for Epidermolysis Bullosa Simplex Clinical Research
Castle Creek Pharmaceuticals
PR-M01-18-NI-065Jan 22, 2018